Johnson & Johnson declared millions of doses of the coronavirus vaccine substandard
The Food and Drug Administration, the US drug regulator, on Wednesday rejected a large quantity of Johnson & Johnson’s vaccine designed to fight the coronavirus because it was substandard. The reason for this is said to be the loss of one and a half crore doses of vaccine by the company.
According to the details, one of the ten companies licensed by Johnson & Johnson to develop the vaccine did not meet the ingredients in the vaccine developed by Emergency Bio Solutions.
